The Promise of Regenerative Medicine and AI

Submitted by amourti on

 

Today, treatments based on laboratory-cultured cells are curing cancer patients. Besides cancer, cell-based therapies have the potential to heal and rejuvenate patients suffering from diseases like Parkinson’s, Alzheimer’s, diabetes and heart disease. In parallel, the technology behind artificial neural networks has made strides in the past years. Jointly, these seemingly unrelated technologies could transform healthcare as we know it. Digital technologies in AI, developed at CERN for high-energy physics, might be promising for this field.

During this seminar, Peter Egelberg, Founder and CEO of Phase Holographic Imaging (PHI), will present the work carried out by PHI in the development of time-lapse cytometry instrumentation and software.

To be kept informed of KT Seminars please sign up at: http://cern.ch/go/F9cX

 

Type
Lecture
Timezone
Europe/Zurich
Location
CERN
Room
40/S2-A01
Category
KT Seminars
Category ID
9700
Indico iCal
https://indico.cern.ch/export/event/1263563.ics
Room Map URL
https://maps.cern.ch/mapsearch/mapsearch.htm?n=['40/S2-A01']
Start Date
End Date